PL1789412T3 - Krystaliczna zasada alfuzosyny - Google Patents

Krystaliczna zasada alfuzosyny

Info

Publication number
PL1789412T3
PL1789412T3 PL04770711T PL04770711T PL1789412T3 PL 1789412 T3 PL1789412 T3 PL 1789412T3 PL 04770711 T PL04770711 T PL 04770711T PL 04770711 T PL04770711 T PL 04770711T PL 1789412 T3 PL1789412 T3 PL 1789412T3
Authority
PL
Poland
Prior art keywords
alfuzosin base
hours
crystalline
base
solution
Prior art date
Application number
PL04770711T
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy Dasari Muralidhara
Reddy Matta Ramakrishna
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of PL1789412T3 publication Critical patent/PL1789412T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Saccharide Compounds (AREA)
PL04770711T 2004-09-16 2004-09-16 Krystaliczna zasada alfuzosyny PL1789412T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IN2004/000292 WO2006030449A1 (en) 2004-09-16 2004-09-16 Crystalline alfuzosin base
EP04770711A EP1789412B1 (en) 2004-09-16 2004-09-16 Crystalline alfuzosin base

Publications (1)

Publication Number Publication Date
PL1789412T3 true PL1789412T3 (pl) 2008-10-31

Family

ID=36059740

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04770711T PL1789412T3 (pl) 2004-09-16 2004-09-16 Krystaliczna zasada alfuzosyny

Country Status (7)

Country Link
US (1) US20070100143A1 (pl)
EP (1) EP1789412B1 (pl)
AT (1) ATE394395T1 (pl)
DE (1) DE602004013644D1 (pl)
ES (1) ES2305848T3 (pl)
PL (1) PL1789412T3 (pl)
WO (1) WO2006030449A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019227A1 (en) * 2003-08-22 2005-03-03 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cephalosporin antibiotic
WO2006090268A2 (en) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
US20090069562A1 (en) * 2005-12-26 2009-03-12 Joseph Prabahar Koilpillai Process for the preparation of alfuzosin
WO2008015525A2 (en) * 2006-07-31 2008-02-07 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of alfuzosin hydrochloride
WO2007063556A2 (en) * 2006-12-07 2007-06-07 Msn Laboratories Limited An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs
CN101687859A (zh) 2007-05-04 2010-03-31 阿克塔维什集团Ptc公司 阿呋唑嗪及其盐的制备工艺
IT1390760B1 (it) * 2008-07-21 2011-09-23 Lundbeck Pharmaceuticals Italy Spa Metodo di preparazione di alfuzosin cloridrato anidro
CN108069945A (zh) * 2017-12-31 2018-05-25 威海贯标信息科技有限公司 一种阿夫唑嗪新晶型
CN114874223B (zh) * 2022-05-25 2023-12-22 宁夏东吴农化股份有限公司 一种从噁二嗪废水中提取乌洛托品的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
US4354921A (en) * 1981-07-27 1982-10-19 Texaco Inc. Solvent dewaxing process
US4668768A (en) * 1985-11-25 1987-05-26 General Electric Company Anti-solvent precipitation process for isolating polymers from solution
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
GB0605688D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7923026B2 (en) * 2006-10-20 2011-04-12 Solvay Pharmaceuticals B.V. Embedded micellar nanoparticles

Also Published As

Publication number Publication date
EP1789412A1 (en) 2007-05-30
EP1789412B1 (en) 2008-05-07
DE602004013644D1 (de) 2008-06-19
US20070100143A1 (en) 2007-05-03
ES2305848T3 (es) 2008-11-01
WO2006030449A1 (en) 2006-03-23
ATE394395T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
CA2555804A1 (en) Polymorphic form of imatinib mesylate and a process for its preparation
PL1789412T3 (pl) Krystaliczna zasada alfuzosyny
IL187421A (en) Process for the synthesis of 5-(methyl-1h-imidazol-1-yl)-3-(tri fluoromethyl)-benzeneamine
WO2009000442A8 (en) Processes for the preparation of pyrazoles
MX2008008447A (es) Proceso para la preparacion de imatinib.
MY134921A (en) Process for the industrial synthesis of strontium ranelate and its hydrates
ZA201003751B (en) Process for the synthesis of propargylated aminoindan derivatives
TW200726750A (en) Stilbene derivatives, light-emitting element and light-emitting device
MX2009010243A (es) Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
ES2452940T3 (es) Procedimiento novedoso de preparación de base de imatinib
WO2009008287A1 (ja) 4-(トリクロロメチルチオ)アニリン類およびその製造方法、ならびに4-(トリフルオロメチルチオ)アニリン類の製造方法
MX2007004638A (es) Proceso para la preparacion de pirazoles.
IL149526A0 (en) Process for the preparation of ketimines
WO2004037766A3 (en) Process for the preparation of 2,6-dihalo-para-trifluoromethylaniline
WO2005080329A3 (en) Process for manufacture of racemic carvedilol
JP2003512370A5 (pl)
MX2008000011A (es) Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos.
WO2001027092A3 (en) Process to prepare aryltriazolinones and novel intermediates thereto
AU2003261853A1 (en) Process for preparing azo compound
WO2004020439A3 (en) Improved process for preparation of risperidone
CN100546979C (zh) 一种4-[4-(二乙基胺基)苯基]甲烯基-5-乙氧基-2,4-二氢-2-苯基-3h-吡唑-3-酮的制备方法
MXPA05003881A (es) Preparacion de compuestos triazospiro.
AR034824A1 (es) Proceso para la preparacion de acitretina
CA2375625A1 (en) Process for production of substituted 1-(2-benzothiazolyl) alkylamine derivative
KR20060087891A (ko) 8-(2-피리미디닐)-8-아자-5-아조니아스피로[4.5]데칸설포네이트 염을 이용하여 아자피론 또는 그의 염을제조하는 방법 및 상기 방법에 사용되는 중간체